General Info

Dr. Torok's primary research interests are in the pathomechanisms of liver fibrosis and matrix remodeling, and exploring translational aspects to prevent or improve fibrosis. Clinically, metabolic dysfunction associated steatohepatitis (MASH) is becoming the leading cause of chronic liver disease and liver cancer, and her lab is interested in deciphering how dynamic changes in the liver matrix accelerate this process in certain conditions such as type 2 diabetes. Of particular interest are studies on collagen architecture and connectivity and how these are implicated in mechano-sensing.